
### [MONDO:0004805](http://purl.obolibrary.org/obo/MONDO_0004805)
**Label:** leukocyte disease

**Subclasses:** [MONDO:0019438](http://purl.obolibrary.org/obo/MONDO_0019438) (AL amyloidosis), [MONDO:0019315](http://purl.obolibrary.org/obo/MONDO_0019315) (diffuse cutaneous mastocytosis), [MONDO:0019316](http://purl.obolibrary.org/obo/MONDO_0019316) (Maculopapular cutaneous mastocytosis), [MONDO:0009693](http://purl.obolibrary.org/obo/MONDO_0009693) (multiple myeloma), [MONDO:0016586](http://purl.obolibrary.org/obo/MONDO_0016586) (systemic mastocytosis), [MONDO:0018542](http://purl.obolibrary.org/obo/MONDO_0018542) (severe congenital neutropenia), [MONDO:0020331](http://purl.obolibrary.org/obo/MONDO_0020331) (indolent systemic mastocytosis), [MONDO:0019023](http://purl.obolibrary.org/obo/MONDO_0019023) (cutaneous mastocytosis), [MONDO:0004948](http://purl.obolibrary.org/obo/MONDO_0004948) (chronic lymphocytic leukemia), [MONDO:0020333](http://purl.obolibrary.org/obo/MONDO_0020333) (aggressive systemic mastocytosis), [MONDO:0015691](http://purl.obolibrary.org/obo/MONDO_0015691) (hypereosinophilic syndrome), [MONDO:0008742](http://purl.obolibrary.org/obo/MONDO_0008742) (autosomal dominant severe congenital neutropenia), [MONDO:0020334](http://purl.obolibrary.org/obo/MONDO_0020334) (mast cell leukemia), [MONDO:0007926](http://purl.obolibrary.org/obo/MONDO_0007926) (Waldenstrom macroglobulinemia), [MONDO:0005615](http://purl.obolibrary.org/obo/MONDO_0005615) (plasmacytoma), [MONDO:0007950](http://purl.obolibrary.org/obo/MONDO_0007950) (mastocytosis), [MONDO:0007243](http://purl.obolibrary.org/obo/MONDO_0007243) (Burkitts lymphoma), [MONDO:0018905](http://purl.obolibrary.org/obo/MONDO_0018905) (diffuse large B-cell lymphoma), [MONDO:0018906](http://purl.obolibrary.org/obo/MONDO_0018906) (follicular lymphoma), [MONDO:0017834](http://purl.obolibrary.org/obo/MONDO_0017834) (secondary hypereosinophilic syndrome), 

**Corr. equiv. classes:** [Orphanet:486](http://www.orpha.net/ORDO/Orphanet_486), [Orphanet:33226](http://www.orpha.net/ORDO/Orphanet_33226), [Orphanet:86855](http://www.orpha.net/ORDO/Orphanet_86855), [OMIM:153600](http://purl.obolibrary.org/obo/OMIM_153600), [Orphanet:85443](http://www.orpha.net/ORDO/Orphanet_85443), [Orphanet:2467](http://www.orpha.net/ORDO/Orphanet_2467), [Orphanet:67038](http://www.orpha.net/ORDO/Orphanet_67038), [OMIM:154800](http://purl.obolibrary.org/obo/OMIM_154800), [Orphanet:66646](http://www.orpha.net/ORDO/Orphanet_66646), [Orphanet:42738](http://www.orpha.net/ORDO/Orphanet_42738), [OMIM:254500](http://purl.obolibrary.org/obo/OMIM_254500), [OMIM:202700](http://purl.obolibrary.org/obo/OMIM_202700), [Orphanet:98850](http://www.orpha.net/ORDO/Orphanet_98850), [Orphanet:98851](http://www.orpha.net/ORDO/Orphanet_98851), [Orphanet:79456](http://www.orpha.net/ORDO/Orphanet_79456), [Orphanet:79457](http://www.orpha.net/ORDO/Orphanet_79457), [Orphanet:98292](http://www.orpha.net/ORDO/Orphanet_98292), [Orphanet:29073](http://www.orpha.net/ORDO/Orphanet_29073), [OMIM:113970](http://purl.obolibrary.org/obo/OMIM_113970), [Orphanet:98848](http://www.orpha.net/ORDO/Orphanet_98848), [Orphanet:168956](http://www.orpha.net/ORDO/Orphanet_168956), [Orphanet:544](http://www.orpha.net/ORDO/Orphanet_544), [Orphanet:543](http://www.orpha.net/ORDO/Orphanet_543), [Orphanet:314962](http://www.orpha.net/ORDO/Orphanet_314962), [Orphanet:545](http://www.orpha.net/ORDO/Orphanet_545), 

**Class expressions from DL-Learner:**

- [HP:0100495](http://purl.obolibrary.org/obo/HP_0100495) (Mastocytosis) 66.00%
- [HP:0100494](http://purl.obolibrary.org/obo/HP_0100494) (Abnormal mast cell morphology) 66.00%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and [HP:0010974](http://purl.obolibrary.org/obo/HP_0010974) (Abnormality of myeloid leukocytes) and [HP:0010978](http://purl.obolibrary.org/obo/HP_0010978) (Abnormality of immune system physiology) 60.77%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and [HP:0010978](http://purl.obolibrary.org/obo/HP_0010978) (Abnormality of immune system physiology) 58.64%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and [HP:0010974](http://purl.obolibrary.org/obo/HP_0010974) (Abnormality of myeloid leukocytes) 58.10%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) 48.74%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 46.71%
- [HP:0010974](http://purl.obolibrary.org/obo/HP_0010974) (Abnormality of myeloid leukocytes) 46.35%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) 44.87%
- [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) 42.66%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 41.85%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 39.67%
- Thing 39.66%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 39.66%
- [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 31.45%


